Subscribe to Newsletter
Subspecialties Microbiology and immunology, COVID-19, Genetics and epigenetics, Training and education

Business in Brief

Credit: Image sourced from

Express Diagnosis

KSL Beutner Laboratories has launched a highly accurate indirect immunofluorescence serum blood test to detect laminin 332, which is associated with the chronic autoimmune disease mucous membrane pemphigoid (1). The assay means that people with the condition won’t have to wait months for a diagnosis; the process could be reduced to 72 hours or less.

Two is Better than One

DNAnexus and Twist Bioscience have announced a collaboration to accelerate research and reduce the time it takes to design, validate, and commercialize novel next-generation sequencing-based tests (2). The partnership will enable customers to combine the integrated DNAnexus platform with two of Twist Bioscience’s products to simplify post-sequencing data analysis.

Variant-Proof Plan

Funded by the Coalition for Epidemic Preparedness Innovations, a consortium partnership has been announced between ExcellGene, Bharat Biotech, and the University of Sydney (3). It aims to advance a new vaccine concept that provides cross-reactive protection against SARS-CoV-2 variants of concern and other betacoronaviruses.

Going Viral

Georgetown University has been awarded US$12.5 million from the National Science Foundation to establish a collaborative institute dedicated to researching and advancing education on viral emergence (4). The Verena Biology Integration Institute aims to develop cross-disciplinary research and train scientists at all career stages on the host-virus network, as well as on core scientific skills.

Do No Harm

The US FDA is reassessing its requirement for products under its jurisdiction to undergo animal testing – suggesting that new alternative methods, such as microphysiological sysems with cellular and computational models, may provide better results and bring products to market faster without the associated ethical concerns (5).

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. 2022 AACC Annual Scientific Meeting Press Program (2022). Available at:
  2. Business Wire (2022). Available at:
  3. BC3 Newswire (2022). Available at:
  4. Georgetown University Medical Center (2022). Available at:
  5. Britt E. Erickson (2022). Available at:
About the Author
Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine